Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC (DPHAY) Stock Overview
Explore Dechra Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.6B
P/E Ratio
-150.57
EPS (TTM)
$-0.63
ROE
-0.04%
DPHAY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Dechra Pharmaceuticals PLC (DPHAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $136.10.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -150.57 and a market capitalization of 5.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.